Henry Schein (0L3C.L) • LSE
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
You don't hold 0L3C.L in your mock portfolio yet.
With a PE ratio of 16.45 and EPS of 4.59, Henry Schein is trading at a reasonable valuation relative to earnings, suggesting the market views it as a stable, mature business rather than a high‑growth story. The metrics point to solid, but not explosive, profitability consistent with a defensive healthcare distributor. Overall, the financial profile looks steady and adequately profitable, but not strongly growth‑oriented based on the limited data provided.
The stock trades at $75.46, modestly above its 200‑day moving average of $74.62, with a 1.0% gain over the last month, signaling a mild positive trend but no strong breakout. An RSI of 53.67 is near the middle of the range, indicating neither overbought nor oversold conditions. Overall, price action and technicals suggest a stable, slightly constructive setup without a clear directional conviction.
Website traffic of roughly 876k visitors per month and app downloads of about 6,000 per day indicate solid digital engagement, but without prior baselines it is hard to infer acceleration. Job openings at 244, down 9.6% month over month, may signal cautious hiring or efficiency efforts rather than aggressive expansion. Social media followings are large and mostly flat to slightly up, suggesting stable brand presence but no surge in customer or stakeholder interest.
Overall, Henry Schein’s stock setup appears neutral: fundamentals and valuation look reasonable, technicals are mildly constructive but not strongly trending, and alternative data show stable rather than accelerating business momentum. The data support a view of a steady, defensive name with modest growth expectations rather than a clear bullish or bearish inflection. Near‑term performance is likely to track incremental changes in earnings and broader healthcare demand rather than dramatic sentiment shifts.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Upgrade to see the full Evidence Stack
What Changed, Why Now, and Risk Flags — available on the Investor plan and above
Get Started